Establishment Labs Holdings Inc. (ESTA)
| Market Cap | 2.21B |
| Revenue (ttm) | 211.08M |
| Net Income (ttm) | -51.06M |
| Shares Out | 29.06M |
| EPS (ttm) | -1.72 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 609,406 |
| Open | 76.83 |
| Previous Close | 78.70 |
| Day's Range | 74.07 - 77.74 |
| 52-Week Range | 26.56 - 83.31 |
| Beta | 0.94 |
| Analysts | Strong Buy |
| Price Target | 82.63 (+8.59%) |
| Earnings Date | Feb 24, 2026 |
About ESTA
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgeries. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force in Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and North America. Establishment Labs Holdings Inc. was incorporated in 2004 and ... [Read more]
Financial Performance
In 2025, ESTA's revenue was $211.08 million, an increase of 27.14% compared to the previous year's $166.03 million. Losses were -$51.06 million, -39.64% less than in 2024.
Financial StatementsAnalyst Forecast
According to 8 analysts, the average rating for ESTA stock is "Strong Buy." The 12-month stock price target is $82.63, which is an increase of 8.59% from the latest price.
News
Carillon Eagle Small Cap Growth Fund Q4 2025 Portfolio Review
Coherent is expected to continue to benefit from a transition to products that enable faster throughput speeds, while prior constraints on manufacturing capacity appear to be alleviating. BrightSpring...
Establishment Labs Holdings Inc. (ESTA) Q4 2025 Earnings Call Transcript
Establishment Labs Holdings Inc. (ESTA) Q4 2025 Earnings Call Transcript
Establishment Labs Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Guidance
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...
Establishment Labs Announces Leadership Transition to Support Next Phase of Growth
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...
Establishment Labs to Present at TD Cowen's 46th Annual Health Care Conference
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...
Baron Discovery Fund Q4 2025: Winners, Laggards, Buys & Sells
In the fourth quarter of 2025, the Baron Discovery Fund returned 0.19% (Institutional Shares), trailing the Russell 2000 Growth Index by 1.03%. In these periods, low quality (high debt and poor profit...
Establishment Labs to Announce Fourth Quarter 2025 Financial Results on February 24
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...
Establishment Labs: The Pivot From Growth To Profitable Scale
Establishment Labs is transitioning to positive cash flow, ending its cash burn era and justifying its premium valuation. ESTA achieved 20% U.S. breast augmentation market share in under 18 months, ou...
Establishment Labs Holdings Inc. (ESTA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Establishment Labs Holdings Inc. (ESTA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Establishment Labs Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...
Establishment Labs to Present at 44th Annual J.P. Morgan Healthcare Conference
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...
Establishment Labs Submits to FDA for Approval of Motiva Implants in Breast Reconstruction
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...
Establishment Labs to Present at Jefferies London Healthcare Conference
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...
Establishment Labs Holdings Inc. (ESTA) Q3 2025 Earnings Call Transcript
Establishment Labs Holdings Inc. ( ESTA) Q3 2025 Earnings Call November 5, 2025 8:30 AM EST Company Participants Rajbir Denhoy - Chief Financial Officer Filippo Caldini - CEO & Director Conference Ca...
Establishment Labs Reports Third Quarter 2025 Financial Results
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...
Establishment Labs to Announce Third Quarter 2025 Financial Results on November 5
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...
Establishment Labs Notes Publication of Mia Femtech 3-Year Prospective Study Results in Aesthetic Surgery Journal
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...
Establishment Labs Publishes 15 Years of Motiva Data in 2025 Post-Market Surveillance Report
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...
Establishment Labs Holdings Inc. (ESTA) Q2 2025 Earnings Call Transcript
Establishment Labs Holdings Inc. (NASDAQ:ESTA) Q2 2025 Earnings Conference Call August 7, 2025 8:30 AM ET Company Participants Fillipo Peter Caldini - CEO & Director Rajbir Singh Denhoy - Chief Finan...
Establishment Labs Reports Second Quarter 2025 Financial Results
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...
Establishment Labs to Announce Second Quarter 2025 Financial Results on August 7
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...
Establishment Labs Hosting Investor Day on June 12
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...
Establishment Labs to Present at Jefferies Global Healthcare Conference
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...
Establishment Labs Holdings, Inc. (ESTA) Q1 2025 Earnings Call Transcript
Establishment Labs Holdings, Inc. (NASDAQ:ESTA) Q1 2025 Earnings Conference Call May 7, 2025 4:30 PM ET Company Participants Peter Caldini - Chief Executive Officer Rajbir Denhoy - Chief Financial Of...
Establishment Labs Appoints Peter Caldini as Chief Executive Officer
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...